From a practical perspective, these findings suggest that combining NT-proBNP, suPAR, galectin-3, and urinary NGAL with standard clinical parameters may improve the early identification of SSc patients at higher risk of CRS. The gene discussed is LGALS3; the disease is congenital rubella syndrome.